YRYan Ren

Yan Ren

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Yan Ren has a total of 32 co-authors. Here are the top co-authors by number of shared publications:

  • Zhe Wang

    Shihezi Univ, Sch Med, Affiliated Hosp 1, Minist Educ,Dept Pathol, Shihezi, Peoples R China

    3 shared publications
  • Chuangfu Chen

    College of Animal Science and Technology, Shihezi University, Shihezi, 832000, China.

    2 shared publications
  • Hongwei Dang

    Shihezi Univ, Affiliated Hosp 1, Dept Obstet & Gynecol, Shihezi 832000, Xinjiang, Peoples R China

    2 shared publications
  • Lijuan Pang

    Shihezi Univ, Sch Med, Affiliated Hosp 1, Minist Educ,Dept Pathol, Shihezi, Peoples R China

    2 shared publications
  • Xuxuan Zhang

    Shihezi Univ, Sch Med, Affiliated Hosp 1, Minist Educ,Dept Pathol, Shihezi, Peoples R China

    2 shared publications
  • A. Howell

    Pediatrics-Neonatology, University of Rochester Medical Center, Rochester, NY, United States

    1 shared publication

Latest Publications

    • 1 January 2022
      • Vol. 15  (1) , 1-10

    Analysis of Xinjiang HPV16 L1 gene polymorphisms: a newly developed, low-cost enzyme-linked immunosorbent assay

    by Zhe Wang, Yan Tang, Hongwei Dang, Xuxuan Zhang, Lijuan Pang, Pengyan Wang, Chuangfu Chen, Yan Ren

    Background: Xinjiang, China shows the world's highest incidence and mortality rates of cervical cancer. Due to limited conditions available for medical examination, hybrid capture 2 (HC2) and other detection methods are used rarely, and early screening for human papillomavirus (HPV) cannot be carried out. Therefore, we estab-lished a double-antibody sandwich (DAS)-enzyme-linked immunosorbent assay (ELISA) based on a polymorphism of the Xinjiang HPV16 L1 strain (KU721788). Methods: According to the conserved sequence and specific epitope of Xinjiang strain HPV16 L1, we prepared two anti-HPV16 L1 monoclonal antibodies and combined them to construct a DAS-ELISA. Detection conditions for the DAS-ELISA were optimized, and HC2 was used as the control to verify the specificity, repeatability and coincidence detection of the DAS-ELISA. Results: The optimized conditions for the DAS-ELISA were: dilution of the capture antibody was 1:100; the enzyme-labelled antibody was 1:10; the sample reaction time was 45 min; the enzyme-labelled antibody was applied for 40 min, and the substrate color develop-ment time was 15 min. The quality of the DAS-ELISA for the detection of HPV 16 was very high, and there was no significant difference when compared with HC2. Conclusion: The DAS-ELISA developed on the basis of the Xinjiang strain (KU721788) polymorphism possesses the advantages of a detection rate similar to that for the HC2 assay currently used clinically, but it is more convenient operationally and at lower cost. DAS-ELISA is thus easier to imple-ment for cervical cancer screening in economically depressed areas.

  • ANXA2 is a Potential Marker for the Diagnosis of Human Cervical Cancer

    by Zhe Wang, Chenhao Jiang, Lijuan Pang, Wei Jia, Chengyan Wang, Xiangting Gao, Xuxuan Zhang, Hongwei Dang, Yan Ren

    Aim: The aim is to study ANXA2 biomarkers for early diagnosis of cervical cancer. Materials & methods: The study used bioinformatics analysis and experimental verification of ANXA2 expression in ce...


  • Open Access

    Surprising Cellular Characteristics of Primary Human Pediatric Lung Mesenchymal Stromal Cells and Fibroblasts

    by R. Misra, A. Howell, C. Wyman, S. Trocke, Y. Ren, H. Hyuck, S. Romas, C. Poole, B. Reeves, T. Nicola, et al.


    • 1 January 2019
      • Vol. 12  (10) , 3940-3943

    Ewing's sarcoma/peripheral primitive neuroectodermal tumor with extraskeletal myxoid chondrosarcoma-like areas: a case report

    by Zhe Wang, Hongwei Dang, Jinfang Jiang, Xiuxia Liu, Weihua Liang, Yan Ren

    Introduction: Ewing's sarcoma (EWS)/peripheral primitive neuroectodermal tumor (pPNET) (EWS/pPNET) is a group of highly aggressive small round cell tumors of the bone or soft tissue with high metastatic potential and an aggressive course in children and young adults. EWS/pPNET microscopically does not often have a myxoid background. Case description: We report an EWS/pPNET, which exhibited an unusual morphology with cells having an acidophilic cytoplasm set in a myxoid background, raising the possibility of extraskeletal myxoid chondrosarcoma (EMC). A reverse transcription-polymerase chain reaction analysis confirmed the presence of an EWS-FLI1 fusion transcript. Conclusions: Morphology, immunohistochemistry, and molecular assays may be necessary to avoid a potential diagnostic pitfall as EWS/pPNET with a myxoid background may histologically resemble an EMC.

  • Open Access

    Inhibition of foot-and-mouth disease virus replication in vitro and in vivo by small interfering RNA

    by Wang Pengyan, Ren Yan, Guo Zhiru, Chen Chuangfu

    By using bioinformatics computer programs, all foot-and-mouth disease virus (FMDV) genome sequences in public-domain databases were analyzed. Based on the results of homology analysis, 2 specific small interfering RNA (siRNA) targeting homogenous 3D and 2B1 regions of 7 serotypes of FMDV were prepared and 2 siRNA-expression vectors, pSi-FMD2 and pSi-FMD3, were constructed. The siRNA-expressing vectors were used to test the ability of siRNAs to inhibit virus replication in baby hamster kidney (BHK-21) cells and suckling mice, a commonly used small animal model. The results demonstrated that transfection of BHK-21 cells with siRNA-expressing plasmids significantly weakened the cytopathic effect (CPE). Moreover, BHK-21 cells transiently transfected with short hairpin RNA (shRNA)-expressing plasmids were specifically resistant to the infection of the FMDV serotypes A, O, and Asia I and this the antiviral effects persisted for almost 48 hours. We measured the viral titers, the 50% tissue culture infective dose (TCID50) in cells transfected with anti-FMDV siRNAs was found to be lower than that of the control cells. Furthermore, subcutaneous injection of siRNA-expressing plasmids in the neck of the suckling mice made them less susceptible to infection with O, and Asia I serotypes of FMDV.